Legacy Education Inc Stock Price, News & Analysis

Legacy Education (NYSE:LGCY) reported robust financial results for fiscal year 2025, with revenue surging 39.5% to $64.2 million. The company achieved significant growth metrics, including a 26.9% increase in new student starts and a 41.8% higher student population of 3,101 compared to 2024.

Key financial highlights include net income of $7.5 million, diluted EPS of $0.59, and adjusted EBITDA of $11.0 million. The fourth quarter was particularly strong with revenue growth of 40.8% to $17.9 million and net income of $1.2 million.

Strategic developments include approval of 3 new degree programs and 2 certificate programs, NLN CNEA Initial Accreditation for the RN-BSN Track, and strengthened leadership with 2 new board members and an advisory board establishment.

Legacy Education (NYSE American: LGCY), a leading provider of career education healthcare programs, has scheduled its Q4 and fiscal year-end 2025 earnings conference call for Thursday, September 25, 2025 at 4:30 p.m. ET.

The company will release its financial results by 4:05 p.m. ET on the same day. Investors can access the live webcast through Legacy Education's investor relations website. Participants can join via teleconference with toll-free number (877) 407-9785 or international number (201) 689-8843. The webcast recording will be available for 90 days on the company website.

Legacy Education (NYSE American: LGCY) has strengthened its Board of Directors with two notable appointments. Dr. Zwade J. Marshall, Co-Founder and CEO of Doc2Doc Lending and CMO at Regenerative Spine and Pain Specialists, brings expertise in clinical medicine and financial innovation. Janis L. Paulson, former CEO of Unitek Learning, contributes over 30 years of healthcare career education leadership experience.

Dr. Marshall, a Harvard-trained board-certified anesthesiologist, holds multiple degrees from Emory University including an MBA and MD. Ms. Paulson, with extensive accreditation experience and a background at Ernst & Young, previously managed an 18-campus educational system in California.

Legacy Education (NYSE: LGCY) has expanded its healthcare education portfolio with four new programs approved by the Accrediting Council for Continuing Education & Training (ACCET). High Desert Medical College will offer Surgical Technology Associate and Sterile Processing Technician Certificate programs across its California locations. Central Coast College will introduce Cardiac Sonography and MRI Associate degree programs.

These strategic additions aim to address the growing demand for healthcare professionals while providing students with pathways to stable careers. The programs will be offered across Legacy's institutions in Lancaster, Bakersfield, Temecula, and Salinas, California, strengthening the company's position in healthcare education.

Legacy Education (NYSE American: LGCY), a career-focused education and training provider, announced its participation in the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025, at the Lotte New York Palace Hotel.

CEO LeeAnn Rohmann will present on September 10, 2025, from 12:30 PM to 1:00 PM EST. Both CEO Rohmann and CFO Brandon Pope will be available for one-on-one meetings throughout the event to provide company overview to interested parties.

Legacy Education (NYSE American: LGCY) announced that its institution, Integrity College of Health (ICH), has received initial accreditation from the National League for Nursing Commission for Nursing Education Accreditation (NLN CNEA) for its Bachelor of Science in Nursing RN-BS Track (Distance) program.

The accreditation validates that ICH's RN-BS program meets national standards and demonstrates academic excellence. Dr. Michelle Welch, VP of Nursing at Legacy Education, emphasized that this achievement reflects their commitment to providing evidence-based, accessible curriculum aligned with healthcare system demands.

The accreditation allows ICH to use the NLN CNEA Accredited logo in its marketing materials, strengthening its position in nursing education.

Legacy Education (NYSE: LGCY) reported strong Q3 FY2025 results with significant growth across key metrics. Revenue increased 50.7% to $18.6 million compared to Q3 FY2024. The company achieved net income of $2.8 million with diluted EPS of $0.21. Student enrollment grew substantially, reaching 3,245 students, representing a 49.8% increase year-over-year. New student starts surged 70.7% to 1,227, including 468 students from the CCMCC acquisition. For the nine months ended March 31, 2025, revenue grew 39% to $46.2 million with net income of $6.3 million. The company maintained strong financial health with $17.3 million in cash and cash equivalents and total stockholders' equity of $39.3 million.

Legacy Education Inc. (NYSE American: LGCY), a provider of career-focused education and training, announced its participation in the upcoming Ladenburg Thalmann Technology Innovation EXPO25. The event will take place on May 21, 2025, at Convene in New York. CEO LeeAnn Rohmann will present from 2:00pm to 2:25pm EST on Track 3. Both CEO Rohmann and CFO Brandon Pope will be available for one-on-one meetings with investors throughout the event to provide company overview.

Legacy Education Inc. (NYSE American: LGCY) has announced it will release its third quarter fiscal year 2025 financial results on Thursday, May 15, 2025. The company will issue a news release outlining the results by 4:05 p.m. Eastern time, followed by a conference call at 4:30 p.m. Eastern time.

Investors can access the live webcast through the company's investor relations website at www.legacyed.com. Participants can join via teleconference by registering at least 15 minutes before the call starts. The toll-free dial-in number is (877) 407-9785, and the international dial-in number is (201) 689-8843. An archived version of the webcast will be available for 90 days on the company's website.